CTBO (Cantabio Pharmaceuticals) Net Margin %: 0.00% (As of Dec. 2018)


What is Cantabio Pharmaceuticals Net Margin %?

Cantabio Pharmaceuticals CTBO Net Margin % is 0.00% as of Dec. 2018.

Net margin is calculated as Net Income divided by its Revenue. Cantabio Pharmaceuticals's Net Income for the three months ended in Dec. 2018 was $0.34 Mil. Cantabio Pharmaceuticals's Revenue for the three months ended in Dec. 2018 was $0.00 Mil. Therefore, Cantabio Pharmaceuticals's net margin for the quarter that ended in Dec. 2018 was 0.00%.

The historical rank and industry rank for Cantabio Pharmaceuticals's Net Margin % or its related term are showing as below:


CTBO's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Cantabio Pharmaceuticals  (OTCPK:CTBO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Cantabio Pharmaceuticals Net Margin % Related Terms

Cantabio Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Net Margin % Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CTBO vs TNTY, ETNI, NTRR: Net Margin % Comparison

For the Biotechnology subindustry, Cantabio Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantabio Pharmaceuticals Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantabio Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cantabio Pharmaceuticals's Net Margin % falls into.


Cantabio Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cantabio Pharmaceuticals's Net Margin for the fiscal year that ended in Mar. 2018 is calculated as

Net Margin=Net Income (A: Mar. 2018 )/Revenue (A: Mar. 2018 )
=-2.012/0
= %

Cantabio Pharmaceuticals's Net Margin for the quarter that ended in Dec. 2018 is calculated as

Net Margin=Net Income (Q: Dec. 2018 )/Revenue (Q: Dec. 2018 )
=0.343/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Cantabio Pharmaceuticals (CTBO) has a Net Margin % of 0.00% as of Dec. 2018. Net margin is the ratio of total net income to net sales. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Net Margin % too high?
Cantabio Pharmaceuticals' current Net Margin % is 0.00%.
How does Cantabio Pharmaceuticals' Net Margin % compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Net Margin % is 0.00% as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.